News
We recently published a list of 10 AI Stocks That Will Skyrocket. In this article, we are going to take a look at where ...
Mrs Aribeana noted that local manufacturing of pharmaceuticals also presents opportunities for job creation, international ...
Eli Lilly alleges Willow falsely claims its products are safe, effective and superior to its FDA-approved tirzepatide medicines, sold under Lilly's brand names: Mounjaro, which treats diabetes, and ...
As the pharmaceutical industry continues to evolve with increasing regulatory expectations, this success story provides ...
Selling, general and administrative expenses were $2.6 billion in the first quarter, Merck noted, an increase of 3% compared with the first quarter of 2024. The increase was primarily due to higher ...
The committee that paid for the signs has raised over $50,000 and solicited donations from sitting city council members.
The Delhi High Court directed the petitioner pharma companies to place notices in newspapers and issue advisories to doctors, ...
Some tariffs remain in place against key U.S. trading partners, but others have been postponed to give nations time to ...
Pharmacy benefit managers (PBMs) are up to bat in the perpetual blame game between PBMs and the pharmaceutical industry. | ...
Sanofi Q1 2025 revenue rose 10.8% to $10.42 billion, driven by Dupixent and new launches, as earnings climbed 20.1% and 2025 guidance was reaffirmed.
Big Pharma, long a lobbying powerhouse in Washington, is struggling to settle on a strategy for defending itself against ...
Patient Capital Management, a value investing firm, released its “Patient Capital Opportunity Equity Strategy” first quarter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results